Close Menu
Home » Abbott

Abbott

Mar 19, 2019

Abbott Receives CE Mark for Alinity Molecular Diagnostics System, Assays

Abbott said that the MDx platform offers a number of initial assays, including tests for HIV-1, HBV, and HCV, among others.

Feb 15, 2019

Genomtec Plans 2021 Launch for Handheld MDx Platform, Respiratory Disease Panel

Premium

The Polish company recently received 9 million Polish złoty ($2.4 million) from the country's National Center for Research and Development to support its activities.

Jan 23, 2019

Abbott Q4 Diagnostic Revenues Grow 3 Percent

Alere rapid diagnostics revenues were $548 million in the quarter, driven by infectious disease and cardiometabolic testing product sales.

Oct 25, 2018

Abbott Molecular Flu, Strep Tests Get FDA Clearance

Abbott said that the next-generation molecular POC assays have also been CLIA waived for use on the Abbott ID NOW instrument, formerly called Alere i.

Oct 17, 2018

Abbott Q3 Dx Business Grows 43 Percent

Molecular diagnostics revenues rose 5 percent driven in part by growth in infectious disease testing, a core area of diagnostic market focus for the firm.

Sep 25, 2018

Qiagen, NeuMoDx Aim to Quickly Build Out Test Menu for High-Volume MDx Systems

Premium

Qiagen's partnership and merger agreement with NeuMoDx may help it compete with high-volume molecular testing vendors such as Abbott, Hologic, and Roche.

Aug 03, 2018

Abbott's TwistDx Subsidiary to Consolidate Operations in San Diego

Abbott confirmed that the move is a consequence of TwistDx evaluating its operations and strategic direction to align operations and commercial needs.

Jul 30, 2018

FIND Awards Grants for Development of HCV Dx Tests

Several companies will receive grants to develop hepatitis C molecular point-of-care and core antigen diagnostic assays.

Jul 20, 2018

FDA Approves Abbott CDx, Agios Drug for AML Patients With IDH1 Mutation

This drug is the first FDA-approved IDH1 inhibitor and will be used to treat adult patients with relapsed or refractory acute myeloid leukemia.

Jul 18, 2018

Abbott Q2 Organic Dx Revenues Rise 7 Percent Driven by Core Lab, MDx Sales

The firm booked $484 million in revenues for Alere rapid diagnostics in the quarter, led by sales for infectious disease and cardiometabolic testing.

Pages

The Scan

Concerns About Bias in Policies

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Reprogrammable DNA

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Lack of Diversity

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

This Week in Science

In Science this week: whole-genome sequencing of single sperm cells, and more.

What's Popular?

In Abbott

  1. Abbott Receives CE Mark for Alinity Molecular Diagnostics System, Assays

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.